Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting 5 Tips to Avoid an IND Clinical Hold: Regulatory Guidance and Insights By Aurora Sosa October 12, 2020 Consulting Entering a New Clinical Phase of Non-Traditional Data Sources By Nach Davé September 30, 2020 Clinical ResearchPhase 1 - Phase 4 Resources for Childhood Cancer Awareness Month By Premier Research September 22, 2020 Clinical ResearchPhase 1 - Phase 4 Premier Presentations from WODC By Nach Davé September 16, 2020 Consulting Can Your Clinical Data Strategy Keep Pace? By Nach Davé September 3, 2020 Clinical ResearchPhase 1 - Phase 4 Considerations for Applying Adaptive Design Approaches to Early Oncology Studies By Abie Ekangaki August 20, 2020 Previous 1 …20 21 22 23 24 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today